Company: JUNS
Filing Date: 2025-11-20
Form Type: 8-K/A
Source: 0001493152-25-024454
Chunk: 0

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-20
Form: 8-K/A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K/A

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

October 24, 2025

Date of Report (Date of earliest event reported)

JUPITER NEUROSCIENCES, INC.

(Exact name of registrant as specified in its charter)</div>

| Delaware              |     | 001-41265   |     | 47-4828381     |
| (State                
 or other jurisdiction |     | (Commission |     | (IRS           
 Employer       |
| of                    
 incorporation)        |     | File        
 Number)     |     | Identification 
 No.)           |

| 1001                                   
 North US HWY 1, Suite 504, Jupiter, FL |     | 33477 |
| (Address                               
 of principal executive offices)        |     |  -Zip 
  Code |

<div align='center'>(561) 406-6154

Registrant’s telephone number, including area code</div>

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

| ☐ | Written                                                                               
 communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)         |
| ☐ | Soliciting                                                                            
 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)           |
| ☐ | Pre-commencement                                                                      
 communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement                                                                      
 communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Securities registered pursuant to Section 12(b) of the Act:

| Title         
 of each class |     | Trading   
 Symbol(s) |     | Name                                 
 of each exchange on which registered |
| Common        
 Stock         |     | JUNS      |     | Nasdaq                               
 Capital Market                       |

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b